EDIT vs. TSLA
EDIT (Editas Medicine, Inc.) and TSLA (Tesla, Inc.) are both stocks. EDIT operates in Biotechnology (Healthcare), while TSLA operates in Auto Manufacturers (Consumer Cyclical). Over the past 10 years, EDIT returned -21.70%/yr vs 39.56%/yr for TSLA. At a 0.32 correlation, their price movements are largely independent.
Performance
EDIT vs. TSLA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EDIT achieves a 29.02% return, which is significantly higher than TSLA's -9.07% return. Over the past 10 years, EDIT has underperformed TSLA with an annualized return of -21.70%, while TSLA has yielded a comparatively higher 39.56% annualized return.
EDIT
- 1D
- -2.40%
- 1M
- -14.95%
- YTD
- 29.02%
- 6M
- 9.30%
- 1Y
- 38.48%
- 3Y*
- -35.09%
- 5Y*
- -40.81%
- 10Y*
- -21.70%
TSLA
- 1D
- 4.59%
- 1M
- -4.53%
- YTD
- -9.07%
- 6M
- -6.97%
- 1Y
- 38.56%
- 3Y*
- 18.72%
- 5Y*
- 15.43%
- 10Y*
- 39.56%
EDIT vs. TSLA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EDIT Editas Medicine, Inc. | 29.02% | 61.42% | -87.46% | 14.21% | -66.59% | -62.13% | 136.78% | 30.15% | -25.97% | 89.34% |
TSLA Tesla, Inc. | -9.07% | 11.36% | 62.52% | 101.72% | -65.03% | 49.76% | 743.44% | 25.70% | 6.89% | 45.70% |
Correlation
The correlation between EDIT and TSLA is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.34 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since Feb 4, 2016 | 0.32 |
The correlation between EDIT and TSLA shifts across timeframes, from 0.24 (1 year) to 0.34 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
EDIT:
$258.89M
TSLA:
$1.45T
EDIT:
-$1.21
TSLA:
$1.10
EDIT:
6.66
TSLA:
14.75
EDIT:
58.73
TSLA:
17.20
EDIT:
$35.86M
TSLA:
$97.88B
EDIT:
$35.86M
TSLA:
$18.66B
EDIT:
-$76.66M
TSLA:
$10.48B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EDIT vs. TSLA — Risk / Return Rank
EDIT
TSLA
EDIT vs. TSLA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Editas Medicine, Inc. (EDIT) and Tesla, Inc. (TSLA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EDIT | TSLA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.46 | ||
| Sortino ratioReturn per unit of downside risk | -0.10 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.17 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.65 | 1.29 | -0.65 |
| Martin ratioReturn relative to average drawdown | 1.15 | 3.01 | -1.87 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EDIT | TSLA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.41 | 0.87 | -0.46 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.44 | 0.26 | -0.70 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.26 | 0.67 | -0.93 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.20 | 0.73 | -0.93 |
Drawdowns
EDIT vs. TSLA - Drawdown Comparison
The maximum EDIT drawdown since its inception was -98.92%, which is greater than TSLA's maximum drawdown of -73.63%. Use the drawdown chart below to compare losses from any high point for EDIT and TSLA.
Loading charts...
Drawdown Indicators
| EDIT | TSLA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.92% | -73.63% | -25.29% |
Max Drawdown (1Y)Largest decline over 1 year | -59.88% | -29.93% | -29.95% |
Max Drawdown (3Y)Largest decline over 3 years | -91.46% | -53.77% | -37.69% |
Max Drawdown (5Y)Largest decline over 5 years | -98.66% | -73.63% | -25.03% |
Max Drawdown (10Y)Largest decline over 10 years | -98.92% | -73.63% | -25.29% |
Current DrawdownCurrent decline from peak | -97.08% | -16.52% | -80.56% |
Average DrawdownAverage peak-to-trough decline | -62.60% | -22.73% | -39.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 33.66% | 12.84% | +20.82% |
Volatility
EDIT vs. TSLA - Volatility Comparison
Editas Medicine, Inc. (EDIT) has a higher volatility of 31.99% compared to Tesla, Inc. (TSLA) at 14.26%. This indicates that EDIT's price experiences larger fluctuations and is considered to be riskier than TSLA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EDIT | TSLA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 31.99% | 14.26% | +17.73% |
Volatility (6M)Calculated over the trailing 6-month period | 61.53% | 28.15% | +33.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 95.12% | 44.60% | +50.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 94.12% | 58.92% | +35.20% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.83% | 59.14% | +24.69% |
Dividends
EDIT vs. TSLA - Dividend Comparison
Neither EDIT nor TSLA has paid dividends to shareholders.
Financials
EDIT vs. TSLA - Financials Comparison
This section allows you to compare key financial metrics between Editas Medicine, Inc. and Tesla, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
EDIT and TSLA have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EDIT has higher volatility (31.99%) compared to TSLA (14.26%). In terms of maximum drawdown, EDIT dropped -98.92% vs TSLA's -73.63%.
TSLA currently has the higher Sharpe Ratio (0.87 vs 0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EDIT and TSLA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer